Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Equity Ratio (2010 - 2026)

Mimedx recorded quarterly Equity Ratio of 0.79 in Q1 2026, up 5.12% quarter-over-quarter from 0.75 in Q4 2025, and up 4.96% year-over-year from 0.75 in Q1 2025.

Mimedx's Equity Ratio history runs 17 years deep, the most recent figure standing at 0.79 for Q1 2026.

  • In Q1 2026, Equity Ratio rose 4.96% year-over-year to 0.79; the TTM figure through Mar 2026 stood at 0.79 (up 4.96% YoY), while the FY2025 annual figure was 0.75, up 2.32% from the prior year.
  • Equity Ratio came in at 0.79 for Q1 2026 at Mimedx, up from 0.75 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.79 in Q1 2026 to a low of 0.11 in Q3 2022.
  • A 5-year average of 0.4 and a median of 0.7 in 2024 frame the typical range for Equity Ratio.
  • Across the five-year window, Equity Ratio slumped 24147.84% in 2022 and surged 10447.82% in 2024, its largest moves.
  • Mimedx's Equity Ratio stood at 0.1 in 2022, then jumped by 668.98% to 0.6 in 2023, then increased by 22.56% to 0.73 in 2024, then grew by 2.32% to 0.75 in 2025, then grew by 5.12% to 0.79 in 2026.
  • According to Business Quant data, Equity Ratio over the past three periods registered 0.79, 0.75, and 0.75 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn 0.79

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.79
Dec 31, 2025 0.75
Sep 30, 2025 0.75
Jun 30, 2025 0.74
Mar 31, 2025 0.75
Dec 31, 2024 0.73
Sep 30, 2024 0.74
Jun 30, 2024 0.73
Mar 31, 2024 0.70
Dec 31, 2023 0.60
Sep 30, 2023 0.01
Jun 30, 2023 -0.07
Mar 31, 2023 -0.11
Dec 31, 2022 -0.10
Sep 30, 2022 -0.11
Jun 30, 2022 -0.08
Mar 31, 2022 -0.04
Dec 31, 2021 0.00
Sep 30, 2021 -0.03
Jun 30, 2021 -0.04
Mar 31, 2021 -0.04
Dec 31, 2020 0.00
Sep 30, 2020 0.06
Jun 30, 2020 0.15
Mar 31, 2020 0.19
Dec 31, 2019 0.21
Sep 30, 2019 0.22
Jun 30, 2019 0.14
Mar 31, 2019 0.36
Dec 31, 2018 0.40
Dec 31, 2017 0.61
Sep 30, 2017 0.80
Jun 30, 2017 0.74
Mar 31, 2017 0.68
Dec 31, 2016 0.41
Sep 30, 2016 0.68
Jun 30, 2016 0.69
Mar 31, 2016 0.64
Dec 31, 2015 0.26
Sep 30, 2015 0.80
Jun 30, 2015 0.82
Mar 31, 2015 0.81
Dec 31, 2014 0.82
Sep 30, 2014 0.83
Jun 30, 2014 0.87
Mar 31, 2014 0.87
Dec 31, 2013 0.87
Sep 30, 2013 0.78
Jun 30, 2013 0.82
Mar 31, 2013 0.83
Dec 31, 2012 0.57
Sep 30, 2012 0.57
Jun 30, 2012 0.57
Mar 31, 2012 0.47
Dec 31, 2011 0.44
Sep 30, 2011 0.50
Jun 30, 2011 0.53
Dec 31, 2010 0.83